The IHC Foundation: Immunohistochemistry Remains a Core Technology...

добавлена новая статья Health

2025-11-27 11:53:35 -

The IHC Foundation: Immunohistochemistry Remains a Core Technology for HER2 and PD-L1 Testing in Breast and Lung Cancer.

While cutting-edge technologies like Next-Generation Sequencing (NGS) capture headlines, traditional methods like Immunohistochemistry (IHC) remain a fundamental cornerstone of companion diagnostics, especially for the detection of critical protein biomarkers. IHC uses antibodies to visualize the presence and location of specific proteins within a tissue sample, providing not only quantitative...

0 Комментарии 0 Поделились 43 Просмотры 0 предпросмотр